Tech Company Financing Transactions
Underdog Pharmaceuticals Funding Round
On 11/19/2019, Underdog Pharmaceuticals announced $4 million in Seed funding from Kizoo Technology Capital and private investors.
Transaction Overview
Company Name
Announced On
11/19/2019
Transaction Type
Venture Equity
Amount
$3,950,000
Round
Seed
Investors
Kizoo Technology Capital (Lead Investor)
private investors (Harald McPike)
private investors (Michael Antonov)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
110 Pioneer Way J
Mountain View, CA 94041
USA
Mountain View, CA 94041
USA
Phone
Website
Email Address
Overview
Underdog Pharmaceuticals, Inc., is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis and hypercholesterolemia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Kope
Chief Executive Officer
Matthew O'Connor
Browse more venture capital transactions:
Prev: 11/19/2019: Amygdala Neurosciences venture capital transaction
Next: 11/19/2019: Radpay venture capital transaction
Share this article
About Our VC Transactions Data
We record every notable VC transaction. VC transactions on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs